Application of osteocalcin to regulation of exosomes of endothelial progenitor cells
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- XUANWU HOSPITAL OF CAPITAL UNIV OF MEDICAL SCI
- Publication Date
- 2018-04-13
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
Technical field
[0001] The invention relates to the field of biomedicine, in particular to the application of osteocalcin (OCN) in regulating endothelial progenitor cell exosomes. Background technique
[0002] Osteocalcin (OCN), also known as bone Gla protein, or bone γ-Carboxyglutamic Acid Containing Protein (BGLAP or BGP), or bone-dependent vitamin K protein (BoneVitamin K Dependent Protein), It is a structural protein specifically synthesized and secreted by osteoblasts, odontoblasts and hypertrophic chondrocytes. It is one of the components that constitute the bone matrix. Glutamate residues in osteocalcin molecules are converted into gamma-carboxyglutamate (Gla) residues through vitamin K-dependent post-translational modification. The γ-carboxylated osteocalcin molecule contains 3 Gla residues. Active vitamin D promotes the biosynthesis of γ-carboxylated osteocalcin in osteoblasts. γ-carboxylated osteocalcin is called active osteocalcin, which can bind to calcium through ...